Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zilleßen, Pia ^a   Celner, Jennifer ^a   Kretschmann, Anita ^b   Pfeifer, Alexander ^b   Racké, Kurt ^b   Mayer, Peter ^a  

^a Federal Institute for Drugs and Medical Devices BfArM   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; BENZAMIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PIOGLITAZONE; PPARGC1A PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; PYRIDINE DERIVATIVE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; SMALL INTERFERING RNA; TRANSCRIPTOME;

ADIPOCYTE; AGONISTS; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DNA MICROARRAY; DRUG EFFECTS; ENZYMOLOGY; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; METABOLISM; RNA INTERFERENCE; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; BENZAMIDES; CELL DIFFERENTIATION; CELLS, CULTURED; DIPEPTIDYL PEPTIDASE 4; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACID-BINDING PROTEINS; HUMANS; INSULIN; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; PPAR GAMMA; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TRANSCRIPTOME;

EID: 84982082392     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23074     Document Type: Article

References (40)

1. Nicholson, G., & Hall, G. M. Diabetes mellitus: New drugs for a new epidemic. Br J Anaesth. 107, 65-73 (2011
2. Deacon, C. F. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: A comparative review. Diabetes, Obes. Metab. 13, 7-18 (2011
3. Drucker, D. J., & Nauck, M. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696-705 (2006
4. Drucker, D. J. Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes. Diabetes Care 30, 1335-1343 (2007
5. Marguet D., et al. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc. Natl. Acad. Sci. USA 97, 6874-6979 (2000
6. Conarello S. L., et al. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 100, 6825-6830 (2003
7. Kazafeos, K. Incretin effect: GLP-1, GIP, DPP4. Diabetes Res. Clin. Pract. 93 (SUPPL. 1), S32-S36 (2011
8. Lambeir, A. M., Durinx, C., Scharpe, S., & De Meester, I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 40, 209-294 (2003
9. Yazbeck, R., Howarth, G. S., & Abbott, C. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol. Sci. 30, 600-607 (2009
10. Gorrell, M. D. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin. Sci. (Lond) 108, 277-292 (2005
11. Kaji K., et al. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J. Gastroenterol. 49, 481-491 (2014
12. Gorrell, M. D., Gysbers, V., & McCaughan, G. W. CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes. Scand. J. Immunol. 54, 249-264 (2001
13. Ussher, J. R., & Drucker, D. J. Cardiovascular biology of the incretin system. Endocr. Rev. 33, 187-215 (2012
14. Zhong J., et al. Apintu potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation. Diabetes 62, 149-157 (2013
15. Zhong, J., Rao, X., & Rajagopalan, S. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease. Atherosclerosis 226, 305-314 (2013
16. Fleischer, B. CD26: A surface protease involved in T-cell activation. Immunol. Today 15, 180-184 (1994
17. Sell H., et al. Adipose dipeptidyl peptidase-4 and obesity: Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care 36, 4083-4090 (2013
18. Lamers D., et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60, 1917-1925 (2011
19. Dunmore, S. J., & Brown, J. E. The role of adipokines in β -cell failure of type 2 diabetes. J. Endocrinol. 216, T37-T45 (2013
20. Scherer, P. E. Adipose tissue: From lipid storage compartment to endocrine organ. Diabetes 55, 1537-1545 (2006
21. Romacho, T., Elsen, M., Rohrborn, D., & Eckel, J. Adipose tissue and its role in organ crosstalk. Acta Physiol. 210, 733-753 (2014
22. Rosen, E. D., & Spiegelman, B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853 (2006
23. Dobrian A. D., et al. Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice. Am J Physiol Endocrinol Metab 300, E410-21 (2011
24. Antonson, P., Stellan, B., Yamanaka, R., & Xanthopoulos, K. G. Apintu novel human CCAAT/enhancer binding protein gene, C/EBPepsilon, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor alpha/delta locus. Genomics 35, 30-38 (1996
25. Yamanaka R., et al. CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc. Natl. Acad. Sci. USA 94, 6462-6467 (1997
26. Puigserver, P., & Spiegelman, B. M. Peroxisome proliferator-activated receptor-? coactivator 1α (PGC-1α ): Transcriptional coactivator and metabolic regulator. Endocr. Rev. 24, 78-90 (2003
27. Tontonoz, P., & Spiegelman, B. M. Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77, 289-312 (2008
28. Kim, K. A., Kim, J. H., Wang, Y., & Sul, H. S. Pref-1 (Preadipocyte Factor 1) Activates the MEK/Extracellular Signal-Regulated Kinase Pathway to Inhibit Adipocyte Differentiation. Mol. Cell. Biol. 27, 3480-3492 (2007
29. Wang, Y., Zhao, L., Smas, C., & Sul, H. S. Pref-1 Interacts with Fibronectin to Inhibit Adipocyte Differentiation. Mol. Cell. Biol. 30, 2294-2308 (2010
30. Farmer S. R. Transcriptional control of adipocyte formation. Cell Metab. 4 263-73 (2006
31. Mayer, P., Haas, B., Celner, J., Enzmann, H., & Pfeifer, A. Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes. Diabetes Obes. Metab. 13, 791-799 (2011
32. Rosen, E. D., & MacDougald, O. A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell. Biol. 7, 885-896 (2006
33. Cristancho, A. G., & Lazar, M. A. Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell. Biol. 12, 722-734 (2011
34. Lefterova, M. I., & Lazar, M. A. New developments in adipogenesis. Trends Endocrinol. Metab. 20, 107-114 (2009
35. Wang, X. M., Yu, D. M. T., McCaughan, G. W., & Gorrell, M. D. Extra-enzymatic roles of DPIV and FAP in cell adhesion and migration on collagen and fibronectin. Adv. Exp. Med. Biol. 575, 213-222 (2006
36. Han, R., Wang, X., Bachovchin, W., Zukowska, Z., & Osborn, J. W. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation. Sci, Rep. 5, 12348 (2015
37. Harms, M., & Seale, P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252-1263 (2013
38. Wu, J., Cohen, P., & Spiegelman, B. M. Adaptive thermogenesis in adipocytes: Is beige the new brown? Genes Dev. 27, 234-250 (2013
39. Das, S. S., et al. Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose. Diabetes, Metab. Syndr. Obes. Targets Ther. 7, 185-194 (2014
40. Pfeifer A. & Hofmann, A. Lentiviral transgenesis. Methods Mol. Biol. 530, 391-405 (2009